CRISPR Therapeutics AGCRSPNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-466.57M
↓ 189% below average
Average (9y)
$-161.39M
Historical baseline
Range
High:$373.53M
Low:$-673.16M
CAGR
+38.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-466.57M | -109.7% |
| 2023 | $-222.54M | +66.9% |
| 2022 | $-673.16M | -280.2% |
| 2021 | $373.53M | +205.4% |
| 2020 | $-354.44M | -858.3% |
| 2019 | $46.74M | +129.4% |
| 2018 | $-158.94M | -145.9% |
| 2017 | $-64.65M | +5.1% |
| 2016 | $-68.13M | -164.8% |
| 2015 | $-25.73M | - |